文献速递糖尿病肥胖与代谢综合征

三肽肠激素输注与胃旁路术及热量限制的代谢组学效应比较

The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该研究为单盲随机安慰剂对照试验的子分析,比较GLP-1、OXM和PYY三肽联合输注(GOP)与安慰剂、极低热量饮食(VLCD)及Roux-en-Y胃旁路术(RYGB)的代谢组学效应。结果显示GOP除葡萄糖外对代谢物影响甚微,而VLCD和RYGB引起显著代谢组学改变。

要点

  • GOP输注4周主要降低血糖,对血浆和尿液代谢物影响很小。
  • VLCD和RYGB引起广泛的代谢组学改变,与GOP效应明显不同。
  • GOP未能复制RYGB和VLCD的 broader 代谢组学变化。

核心结论

  • GOP治疗提供强效降糖作用,但不重现VLCD和RYGB所见的广泛代谢组学改变。
  • RYGB代谢组学改变对其临床获益的贡献尚待阐明。

研究设计与样本

  • 单盲、随机、安慰剂对照研究的子分析(ClinicalTrials.gov NCT01945840),包含VLCD和RYGB对照组的观察性比较。
  • 另22例患者接受VLCD,21例接受RYGB手术。
  • 基线和干预4周时采集血浆和尿液样本进行跨平台代谢组学分析。

主要发现

  • 除葡萄糖外,GOP对极少数代谢物产生影响。
  • VLCD和RYGB引起显著的代谢组学变化。
  • GOP的代谢组学效应与VLCD和RYGB明显不同。

临床怎么用

  • GOP联合输注可用于强效降糖,但其代谢组学效应不等同于RYGB或VLCD。
  • 不能以GOP的代谢组学变化推断RYGB的广泛代谢获益机制。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The gut-derived peptide hormones glucagon-like peptide-1 (GLP-1), oxyntomodulin (OXM), and peptide YY (PYY) are regulators of energy intake and glucose homeostasis and are thought to contribute to the glucose-lowering effects of bariatric surgery. OBJECTIVE: To establish the metabolomic effects of a combined infusion of GLP-1, OXM, and PYY (tripeptide GOP) in comparison to a placebo infusion, Roux-en-Y gastric bypass (RYGB) surgery, and a very low-calorie diet (VLCD). DESIGN AND SETTING: Subanalysis of a single-blind, randomized, placebo-controlled study of GOP infusion (ClinicalTrials.gov NCT01945840), including VLCD and RYGB comparator groups. PATIENTS AND INTERVENTIONS: Twenty-five obese patients with type 2 diabetes or prediabetes were randomly allocated to receive a 4-week subcutaneous infusion of GOP (n = 14) or 0.9% saline control (n = 11). An additional 22 patients followed a VLCD, and 21 underwent RYGB surgery. MAIN OUTCOME MEASURES: Plasma and urine samples collected at baseline and 4 weeks into each intervention were subjected to cross-platform metabolomic analysis, followed by unsupervised and supervised modeling approaches to identify similarities and differences between the effects of each intervention. RESULTS: Aside from glucose, very few metabolites were affected by GOP, contrasting with major metabolomic changes seen with VLCD and RYGB. CONCLUSIONS: Treatment with GOP provides a powerful glucose-lowering effect but does not replicate the broader metabolomic changes seen with VLCD and RYGB. The contribution of these metabolomic changes to the clinical benefits of RYGB remains to be elucidated.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jones B, Sands C, Alexiadou K, et al. The Metabolomic Effects of Tripeptide Gut Hormone Infusion Compared to Roux-en-Y Gastric Bypass and Caloric Restriction. J Clin Endocrinol Metab. 2022. PMID: 34460933. doi:10.1210/clinem/dgab608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。